Detalhe da pesquisa
1.
Evaluation of the MD Anderson tumor score for diffuse large B-cell lymphoma in the rituximab era.
Eur J Haematol
; 104(5): 400-408, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-31804029
2.
Use and safety of riboflavin and UV light-treated platelet transfusions in children over a five-year period: focusing on neonates.
Transfusion
; 59(12): 3580-3588, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31587287
3.
Our experience in riboflavin and ultraviolet light pathogen reduction technology for platelets: from platelet production to patient care.
Transfusion
; 58(8): 1881-1889, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30132911
4.
Efficacy of the GemOx-R regimen leads to the identification of Oxaliplatin as a highly effective drug against Mantle Cell Lymphoma.
Br J Haematol
; 174(6): 899-910, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27220900
5.
Analysis of vaccine responses after anti-CD20 maintenance in B-cell lymphoma in the Balearic Islands. A single reference center experience.
Front Immunol
; 14: 1267485, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38022668
6.
The International Prognostic Index Is Associated with Outcomes in Diffuse Large B Cell Lymphoma after Chimeric Antigen Receptor T Cell Therapy.
Transplant Cell Ther
; 27(3): 233-240, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33781518
7.
Infection during the first year in patients treated with CD19 CAR T cells for diffuse large B cell lymphoma.
Blood Cancer J
; 10(8): 79, 2020 08 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32759935
8.
DLBCL patients treated with CD19 CAR T cells experience a high burden of organ toxicities but low nonrelapse mortality.
Blood Adv
; 4(13): 3024-3033, 2020 07 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32614964
9.
Comparative Cost Analysis Of Intravenous And Subcutaneous Administration Of Rituximab In Lymphoma Patients.
Clinicoecon Outcomes Res
; 11: 695-701, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31819561
10.
Rhabdomyosarcoma debut masquerading as acute lymphoblastic leukemia: A case report and review of the literature.
Clin Case Rep
; 7(8): 1545-1548, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31428386
11.
Complete response associated with lenalidomide and celecoxib in a case of primary refractory Hodgkin lymphoma.
Onco Targets Ther
; 11: 6599-6603, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30349293
12.
Analysis of the role of intratecal liposomal cytarabine in the prophylaxis and treatment of central nervous system lymphomatosis: The Balearic Lymphoma Group experience.
PLoS One
; 12(6): e0179595, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28665999
13.
Lenalidomide, celecoxib, and azacitidine therapy for blastic plasmocytoid dendritic cell neoplasm: a case report.
Onco Targets Ther
; 9: 5507-11, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27660468